GB1304499A - - Google Patents

Info

Publication number
GB1304499A
GB1304499A GB78572A GB78572A GB1304499A GB 1304499 A GB1304499 A GB 1304499A GB 78572 A GB78572 A GB 78572A GB 78572 A GB78572 A GB 78572A GB 1304499 A GB1304499 A GB 1304499A
Authority
GB
United Kingdom
Prior art keywords
vitamin
pantothenate
jan
anabolisant
tixier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB78572A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1304499A publication Critical patent/GB1304499A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/407Liver; Hepatocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB78572A 1971-01-21 1972-01-07 Expired GB1304499A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7101993A FR2122342B1 (enrdf_load_stackoverflow) 1971-01-21 1971-01-21

Publications (1)

Publication Number Publication Date
GB1304499A true GB1304499A (enrdf_load_stackoverflow) 1973-01-24

Family

ID=9070655

Family Applications (1)

Application Number Title Priority Date Filing Date
GB78572A Expired GB1304499A (enrdf_load_stackoverflow) 1971-01-21 1972-01-07

Country Status (4)

Country Link
BE (1) BE776675A (enrdf_load_stackoverflow)
DE (1) DE2202736A1 (enrdf_load_stackoverflow)
FR (1) FR2122342B1 (enrdf_load_stackoverflow)
GB (1) GB1304499A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871376A4 (en) * 1995-11-09 2004-03-24 Univ Leland Stanford Junior IMPROVING THE VASCULAR FUNCTION BY CONTROLLING THE PRODUCTION AND ACTIVITY OF THE ENDOGENIC NITROGEN MONOXIDE
US7452916B2 (en) 1993-06-11 2008-11-18 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452916B2 (en) 1993-06-11 2008-11-18 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
EP0871376A4 (en) * 1995-11-09 2004-03-24 Univ Leland Stanford Junior IMPROVING THE VASCULAR FUNCTION BY CONTROLLING THE PRODUCTION AND ACTIVITY OF THE ENDOGENIC NITROGEN MONOXIDE

Also Published As

Publication number Publication date
BE776675A (fr) 1972-04-04
DE2202736A1 (de) 1972-08-03
FR2122342B1 (enrdf_load_stackoverflow) 1974-08-02
FR2122342A1 (enrdf_load_stackoverflow) 1972-09-01

Similar Documents

Publication Publication Date Title
CA1021324A (fr) Compositions tinctoriales pour fibres keratiniques et nouvelles diaza-merocyanines entrant dans ces compositions
AU459399B2 (en) Improvements in or relating tothe production of enzyme preparations
GB1330878A (en) Ketamine resolution
GB1341794A (en) Medicament for the treatment of hepatic disorders
GB1304499A (enrdf_load_stackoverflow)
GB1381649A (en) Medicine comprising lysine by-products
GB1387803A (en) Watersoluble salts of polyhydroxyphenylchromanones
GB1319455A (en) Skin preparations
CA956500A (en) Stabilized vitamin c and iron in canned foods
AU466963B2 (en) Improvements in or relating to guides for sewing invisible fasteners
AU2950871A (en) Improvements in and relating to packages
AU460413B2 (en) Stabilized vitamin c and iron in canned foods
AU2345670A (en) "improvements in and relating ot feed supplements for ruminants"
AU2757571A (en) Stabilized vitamin c and iron in canned foods
AU449916B2 (en) 3b - AND 2b -HALO- 5& - STEROID - 2& AND 3& - POLYSULFIDE ADDUCT AND THEIR PREPARATION
CA966422A (en) Compositions containing diazepam and cyclobenzaprine
GB1171599A (en) Dermatological Composition
CA959840A (en) 1,4,2-dioxazine derivatives and preparations
AU441197B2 (en) Novel thienodiazepines and preparations thereof
AU437920B2 (en) Substituted 1,35-triazines and preparations containing them
CA849004A (en) Dermatological preparations containing pilosine, isopilosine and their salts
GB1247295A (en) Improvements in or relating to chairs
AU4541068A (en) Improvements in or relating to nutritional and veterinary preparations
AU436609B2 (en) Improvements in and relating to titanium chelates
AU3575971A (en) Novel thienodiazepines and preparations thereof

Legal Events

Date Code Title Description
PS Patent sealed
PLE Entries relating assignments, transmissions, licences in the register of patents
PCNP Patent ceased through non-payment of renewal fee